DOTA Test: Definition, Procedure, Uses, and Benefits

In most cases, the DOTA test is a PET/CT scan in which the imaging component is a DOTA-based somatostatin receptor scan (most often Ga-68 DOTATATE PET/CT). It can be especially useful in assessing certain neuroendocrine tumors because some of these tumors have somatostatin receptors that can be bound by the radiotracer. The scan can point to the location of tumors, their spread, and whether specific receptor-targeted therapies might apply to the treatment. Molecular Diagnostics and Therapy provides skilled diagnostic evaluation and treatment with the appropriate laboratory and diagnostic service options which complement imaging-based evaluation.

What Is a DOTA Test?

A nuclear medicine imaging examination that uses a radioactive tracer (such as Ga-68 DOTATATE) to detect cells that express somatostatin receptors. Gallium-68 DOTATATE (Ga-68 DOTATATE) is one tracer that is often used. Once given, the tracer locks onto somatostatin receptors on specific cells. The tracer is then picked up by a PET scanner that generates detailed images of the regions where the tracer has been deposited. The type of tracer and imaging procedures may differ from one medical indication to another and depending on availability.

Why Is a DOTA Scan Performed?

DOTA-based PET/CT imaging is commonly used to evaluate neuroendocrine tumors (NETs). It can aid the medical professional in identifying the site of a tumor as well as in confirming its expansion to other parts of the body.

• Locating a suspected neuroendocrine tumor
• Assessing the extent or spread of a known tumor
• Looking for recurrent or metastatic disease
• Evaluating somatostatin receptor expression
• Supporting treatment planning in selected patients

The scan is not appropriate for every type of cancer, and its usefulness depends on the biological characteristics of the suspected or known tumor.

How Is the DOTA Procedure Performed?

The health care team will give instructions on how to prepare for the scan. The following directions may be different according to the tracer and the protocol of the facility.

The radiotracer is given, typically by injection into a vein, during the procedure. A waiting period is allowed for the tracer to be distributed throughout the body and to the relevant receptors.

PET is also performed, usually in combination with an examination of the CT image, on the patient. The radiotracer is detected by the PET component, while anatomical information is provided by the CT component. The images can be used jointly to help health professionals determine the location and distribution of areas of tracer uptake. The entire appointment can take a few hours, depending on whether there is any preparation before the tracer is administered, how long after the tracer is taken to set up the scan, how long it takes to take the scan, and what scans would occur after, such as waiting.

What Can a DOTA Scan Detect?

Increased somatostatin receptor expression can be found with a DOTA-based PET/CT scan. This is especially helpful for many well-differentiated neuroendocrine tumors. Sometimes the scan can be used to help determine whether there is any disease elsewhere in the body, in the bones, liver or lymph nodes, or in the primary tumour. Not all tumours, however, have equally abundant somatostatin receptors, and a negative or low uptake does not rule out all neuroendocrine tumours. Always look at the results in conjunction with the clinical examination and pathological results and other investigations.

Benefits of DOTA PET/CT

A major advantage of DOTA imaging is data obtained regarding the entire body of somatostatin receptor-active disease. This can help medical professionals to have a clearer idea about how a tumor spreads. It might also give information that could be useful for treatment planning. A somatostatin receptor-tracer with high uptake, in selected patients, can be used to assess the potential for receptor-specific radionuclide therapy. The other benefit is that PET/CT brings functional data obtained from PET, with anatomical data from CT, so that findings can be better localized.

Is the DOTA Test Safe?

Exposing the patient to a relatively low amount of radiation from the radiotracer, and if a CT is performed, from the CT component as well, DOTA PET/CT exposes the patient to a small amount of radiation. Weighing the pros and cons, the healthcare team decides to recommend the examination for the patient. Patients should let their healthcare team know about any pregnancy or if they might be pregnant, as well as if they are breastfeeding. The imaging center should give specific instructions regarding medications, hydration, and any other instructions to follow for preparation.

What Happens After the Scan?

For the majority of patients, once the scanning has been done, they may be able to resume their normal daily activities unless they are advised otherwise by their medical staff. Over time, this radiotracer is naturally excreted from the body, mostly in the urine. The interpreting specialist looks at pictures and writes a report to give to the health-care professional. These findings are then correlated with the symptoms, pathology, laboratory findings, and other imaging tests.

DOTA Scan and Other Diagnostic Tests

A DOTA scan is a part of a comprehensive evaluation. Further tests may be done based on the suspected disease, and they could include blood tests, pathology, conventional imaging, molecular testing, and others. For instance, tissue pathology can assist in establishing the tumor type, and molecular investigations can be performed to yield information on specific biological features where clinically applicable.

Conclusion

The DOTA test can be very important in helping diagnose many neuroendocrine tumors (NETs), and DOTA imaging (such as Ga-68 DOTATATE imaging) can be used as part of a PET scan. It may be useful for identifying somatostatin-receptor-positive disease, determining the distribution of the disease in selected patients, monitoring these patients, and may have a role in planning the approach to treatment. Several factors such as diagnosis, symptoms, tumor properties, and clinical needs determine the need for a DOTA scan. Interpretation of the results must be made by qualified health care professionals in the context of a comprehensive diagnostic work-up. To implement this comprehensive approach, Molecular Diagnostics and Therapy provides suitable laboratory or molecular diagnostics services.